KYMR position history
The shares of Kymera Therapeutics (KYMR) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q3: 25,000 shares, $1.2M, <0.01% of portfolio, New
- 2024 Q4: 25,000 shares, $1M, <0.01% of portfolio
- 2025 Q1: not held, Exit
- 2025 Q2: not held
- 2025 Q3: 7,000 shares, $396K, <0.01% of portfolio, New
- 2025 Q4: 20,000 shares, $1.6M, <0.01% of portfolio, Add +185.7%
- 2026 Q1: 20,000 shares, $1.7M, <0.01% of portfolio
- 2026 Q2: 20,000 shares, $2.3M, <0.01% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|